CD30/TNFRSF8 Protein, Human, Recombinant (His & Avi)
Ref. TM-TMPK-00346
| 1mg | 1,986.00 € | ||
| 100µg | 314.00 € | ||
| 500µg | 1,237.00 € |
Estimated delivery in United States, on Friday 7 Jun 2024
Product Information
Name:
CD30/TNFRSF8 Protein, Human, Recombinant (His & Avi)
Synonyms:
- CD30KI-1, CD30L receptor, TNFRSF8, D1S166EKi-1, CD30
Description:
The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in subpopulations of activated T-and B-cells in nonpathologic conditions. CD30 expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs).
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
41.3 kDa (predicted). Due to glycosylation, the protein migrates to 68-95 kDa based on Tris-Bis PAGE result.
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-TMPK-00346 CD30/TNFRSF8 Protein, Human, Recombinant (His & Avi)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
